Cargando…
Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864791/ https://www.ncbi.nlm.nih.gov/pubmed/33556587 http://dx.doi.org/10.1016/j.accpm.2021.100812 |
_version_ | 1783647719434223616 |
---|---|
author | Tonon, David Simeone, Pierre Lagier, David Bourenne, Jérémy Velly, Lionel |
author_facet | Tonon, David Simeone, Pierre Lagier, David Bourenne, Jérémy Velly, Lionel |
author_sort | Tonon, David |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7864791 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78647912021-02-09 Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 Tonon, David Simeone, Pierre Lagier, David Bourenne, Jérémy Velly, Lionel Anaesth Crit Care Pain Med Letter to the Editor Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. 2021-04 2021-02-06 /pmc/articles/PMC7864791/ /pubmed/33556587 http://dx.doi.org/10.1016/j.accpm.2021.100812 Text en © 2021 Société française d'anesthésie et de réanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Letter to the Editor Tonon, David Simeone, Pierre Lagier, David Bourenne, Jérémy Velly, Lionel Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title | Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title_full | Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title_fullStr | Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title_full_unstemmed | Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title_short | Association of ABO blood group with indices of disease severity and multiorgan dysfunction in COVID-19 |
title_sort | association of abo blood group with indices of disease severity and multiorgan dysfunction in covid-19 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864791/ https://www.ncbi.nlm.nih.gov/pubmed/33556587 http://dx.doi.org/10.1016/j.accpm.2021.100812 |
work_keys_str_mv | AT tonondavid associationofabobloodgroupwithindicesofdiseaseseverityandmultiorgandysfunctionincovid19 AT simeonepierre associationofabobloodgroupwithindicesofdiseaseseverityandmultiorgandysfunctionincovid19 AT lagierdavid associationofabobloodgroupwithindicesofdiseaseseverityandmultiorgandysfunctionincovid19 AT bourennejeremy associationofabobloodgroupwithindicesofdiseaseseverityandmultiorgandysfunctionincovid19 AT vellylionel associationofabobloodgroupwithindicesofdiseaseseverityandmultiorgandysfunctionincovid19 |